Daicel Corporation

As of March 31, 2026, Daicel Corporation carries a market capitalization of 312.99B, placing it among publicly traded companies globally. Its enterprise value stands at 563.21B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Daicel Corporation's next confirmed earnings release is scheduled for November 5, 2026.

As of March 31, 2026, Daicel Corporation has 255.39M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Daicel Corporation maintains a current ratio of 2.04, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Daicel Corporation's stock has gained approximately 4.15% over the past 52 weeks. The 50-day moving average sits at 1,448.69, while the 200-day moving average is 1,398.69.

As of March 31, 2026, Daicel Corporation holds 68.81B in cash and equivalents against 304.25B in total debt, resulting in a net debt position of 235.44B. Total book value stands at 355.60B, with working capital of 205.58B providing operational flexibility.

Daicel Corporation's most recent stock split took place on March 27, 1985 with a 10:11 split ratio.